Xylem (NYSE:XYL - Get Free Report) had its price objective reduced by analysts at Mizuho from $130.00 to $110.00 in a note issued to investors on Thursday, Benzinga reports. The firm currently has a "neutral" rating on the industrial products company's stock. Mizuho's target price would indicate a potential upside of 6.39% from the company's previous close.
Several other equities research analysts have also commented on the stock. UBS Group lowered their price target on shares of Xylem from $138.00 to $112.00 and set a "neutral" rating on the stock in a report on Monday, October 5th. CLSA upgraded Xylem to a "hold" rating in a research note on Thursday, June 25th. Stifel Nicolaus raised their target price on Xylem from $157.00 to $160.00 and gave the stock a "buy" rating in a report on Wednesday, July 29th. Citigroup reduced their price target on Xylem from $172.00 to $148.00 and set a "buy" rating for the company in a research report on Monday. Finally, Robert W. Baird boosted their price target on Xylem from $163.00 to $165.00 and gave the company an "outperform" rating in a report on Wednesday, July 29th. Nine equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $145.54.
Read Our Latest Stock Report on XYL
Xylem Stock Performance
NYSE XYL traded up $0.66 during trading hours on Thursday, reaching $103.39. The stock had a trading volume of 604,853 shares, compared to its average volume of 2,064,371. Xylem has a 52-week low of $98.58 and a 52-week high of $154.27. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.24 and a current ratio of 1.61. The stock has a market cap of $24.14 billion, a P/E ratio of 24.62, a price-to-earnings-growth ratio of 1.65 and a beta of 1.00. The stock has a fifty day moving average of $109.07 and a 200 day moving average of $114.07.
Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings data on Tuesday, July 28th. The industrial products company reported $1.46 EPS for the quarter, beating the consensus estimate of $1.34 by $0.12. The business had revenue of $2.34 billion during the quarter, compared to analysts' expectations of $2.34 billion. Xylem had a net margin of 11.15% and a return on equity of 11.77%. The business's quarterly revenue was up 1.5% compared to the same quarter last year. During the same period in the previous year, the business posted $1.26 EPS. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. Sell-side analysts predict that Xylem will post 5.66 earnings per share for the current year.
Institutional Investors Weigh In On Xylem
A number of hedge funds have recently modified their holdings of the business. XXEC Inc. purchased a new position in Xylem in the second quarter valued at $850,841,000. BlackRock Inc. purchased a new stake in Xylem during the 2nd quarter worth about $2,959,730,000. State Street Corp increased its holdings in Xylem by 2.4% during the 2nd quarter. State Street Corp now owns 11,444,669 shares of the industrial products company's stock worth $1,352,874,000 after purchasing an additional 270,972 shares during the period. Swedbank AB raised its position in Xylem by 0.3% in the 1st quarter. Swedbank AB now owns 5,526,725 shares of the industrial products company's stock valued at $660,444,000 after purchasing an additional 18,759 shares in the last quarter. Finally, Royal Bank of Canada raised its position in Xylem by 1.1% in the 1st quarter. Royal Bank of Canada now owns 4,763,241 shares of the industrial products company's stock valued at $569,207,000 after purchasing an additional 53,210 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.
Xylem News Roundup
Here are the key news stories impacting Xylem this week:
- Positive Sentiment: Xylem opened an expanded Flygt distribution and training hub in Toronto, which should strengthen regional customer support, product availability, and training capabilities. Xylem opens expanded Flygt distribution and training hub in Toronto
- Positive Sentiment: Oppenheimer reaffirmed its Outperform rating despite lowering its target to $150 from $158, implying substantial potential upside from recent trading levels. Oppenheimer adjusts Xylem price target
- Neutral Sentiment: RBC Capital maintained an Outperform rating but reduced its price target sharply to $135 from $164, signaling continued confidence in the long-term story while acknowledging weaker near-term expectations. RBC Capital adjusts Xylem price target
- Negative Sentiment: Oppenheimer’s assessment that Xylem’s year-to-date performance reflects fears of sustained top-line pressure reinforces investor concerns about slower revenue growth and limits near-term upside. Xylem year-to-date stock performance
- Negative Sentiment: Mizuho lowered its price target to $110 from $130, while Oppenheimer separately reduced its target to $150 from $158. The repeated target cuts are likely weighing on sentiment, even though analyst ratings remain constructive. Mizuho adjusts Xylem price target
Xylem Company Profile
(
Get Free Report)
Xylem Inc NYSE: XYL is a global water technology company that develops products, services and solutions for the movement, treatment, testing and efficient use of water. Its offerings serve municipal water and wastewater systems, utilities, industrial customers, commercial buildings and other infrastructure operators.
The company's portfolio includes water and wastewater pumps, mixing and aeration equipment, treatment systems, measurement and monitoring technologies, smart metering, network-management software, and related services.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.